Adalys Galvez
Nurse Practitioner · Miami, FLNPI 1285866020
Payments from drug & device makers
Across 64 payments — averaging $107.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novocure Inc.$942
- Daiichi Sankyo Inc.$719
- E.r. Squibb & Sons, L.L.C.$540
- Genentech USA, Inc.$536
- AstraZeneca$498
- Amgen$445
- plus $3K from 19 others
What the payments were for
- Food & beverage$6,868100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novocure Inc. | 10 | $942 |
| Daiichi Sankyo Inc. | 8 | $719 |
| E.r. Squibb & Sons, L.L.C. | 5 | $540 |
| Genentech USA, Inc. | 4 | $536 |
| AstraZeneca | 5 | $498 |
| Amgen | 4 | $445 |
| Seagen Inc. | 3 | $366 |
| Sanofi-aventis U.S. LLC | 3 | $306 |
| Genmab U.S., Inc. | 2 | $249 |
| Jazz Pharmaceuticals Inc. | 2 | $237 |
| Incyte Corporation | 2 | $234 |
| Gilead | 2 | $229 |
| Bristol Myers Squibb | 2 | $213 |
| Exelixis Inc. | 1 | $131 |
| Blueprint Medicines Corporation | 1 | $127 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| Astellas Pharma US Inc | 1 | $124 |
| Progenics Pharmaceuticals, Inc. | 1 | $123 |
| Eisai Inc. | 1 | $122 |
| EMD Serono, Inc. | 1 | $122 |
| Epizyme, Inc. | 1 | $121 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $119 |
| Mirati Therapeutics, Inc. | 1 | $115 |
| Springworks Therapeutics, Inc. | 1 | $99 |
| Novartis | 1 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,868 in reported general payments places this provider in the 95th percentile of 8,290 nurse practitioner providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lacosamide | 81 | $4,817 |
| Levetiracetam | 112 | $2,371 |
| Dexamethasone | 66 | $1,417 |
| Memantine Hcl | 40 | $456 |
| Gabapentin | 18 | $330 |
| Mirtazapine | 26 | $289 |
| Pantoprazole Sodium | 37 | $278 |
| Pregabalin | 11 | $70 |
| Amlodipine Besylate | 16 | $14 |
| Lorazepam | 12 | $9 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Miami
- Margarita FernandezMiami$311K
- Maya BloombergMiami$202K
- Haydee KapinMiami$97K
- Terri PollackMiami$59K
- Amber FederizoMiami$39K
- Patricia Novoa-VogtMiami$35K
- Moriane JosephMiami$23K
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.